Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550861 · ClinicalTrials.gov registry record · NA
In Vitro Maturation (IVM) of Human Oocytes
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01550861: Clinical Trial NA study, sponsored by Weill Medical College of Cornell University.
NCT01550861 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01550861, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the clinical efficacy of Natural in vitro Fertilization and in vitro maturation.
Interventions
- PROCEDURE in vitro maturation
- PROCEDURE Polar Body Biopsy with preimplantation genetic screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-02-15 |
| Est. Completion | 2023-09-18 |
| Phase | NA |
Why NCT01550861 stopped before completion
NCT01550861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which in vitro maturation is the first listed.
NCT01550861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01550861 about?
NCT01550861 is a clinical study titled "In Vitro Maturation (IVM) of Human Oocytes". The objectives of this study are to evaluate the clinical efficacy of Natural in vitro Fertilization and in vitro maturation.
What is the current status of trial NCT01550861?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-02-15. Estimated completion is 2023-09-18.
What interventions are being tested in trial NCT01550861?
The interventions under investigation include: in vitro maturation (PROCEDURE), Polar Body Biopsy with preimplantation genetic screening (PROCEDURE).
Who is sponsoring clinical trial NCT01550861?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01550861's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI